Manufacturer record
AK Krishna Pharma Ltd. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by AK Krishna Pharma Ltd. Ltd (Uttarakhand) were declared Not of Standard Quality between May 2024 and July 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to AK Krishna Pharma Ltd. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Acetylsalicylic Acid 75mg (Kardiorin AK) | JTN23-211Mfg 2023-07 · Exp 2026-06 | Test for Salicylic acid, Assay of Aspirin and DescriptionAssay | CDTL MumbaiCDSCO lab | Jul 2024 |
| Acetylsalicylic Acid Tablets 75 mg | JTN23- 211Mfg 2023-07 · Exp 2026-06 | Sample does not conforms to IP with respect to test for Dissolution.Dissolution | CDL KolkataCDSCO lab | May 2024 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| L-Carnitine, L- Tartarate ,Mecobalamin & Folic Acid Tablets | B95Y032 | SDTL, Assam | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Apr 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.